Data collected throughout the project regarding prospective cohort study for medium- and long-term follow-up in COVID-19 individuals
| Type of Analysis |
Total samples |
Acute phase |
3M FU visit |
6M FU visit |
12M FU visit |
18M FU visit |
24M FU visit |
| NP swabs (viral variants and resp microbiome) |
4182 |
3598 |
346 |
159 |
31 |
31 |
17 |
| Serology |
13369 |
4719 |
1808 |
2101 |
2090 |
1971 |
680 |
| IFN-gamma |
7712 |
2033 |
797 |
1328 |
1404 |
1489 |
661 |
| Cellular immunity (PBMCs) |
3666 |
1036 |
353 |
754 |
797 |
631 |
95 |
| Cytokines |
11256 |
4141 |
994 |
1484 |
2033 |
1941 |
663 |
| Epigenetics |
2827 |
1779 |
417 |
268 |
279 |
83 |
1 |
| Human genomics |
2681 |
1773 |
367 |
207 |
250 |
83 |
1 |
| Intestinal microbiome |
1211 |
1024** |
174 |
3 |
6 |
4 |
0 |
** COVID-Home collected multiple samples per patients (total: 697 rectal swabs/stools); only considered 1 sample perpatient (190)